Myeloma and Related Diseases Registry (MRDR)

Helping clinicians and hospitals to provide the best possible care to people with multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasma cell leukaemia or plasmacytoma.

More information

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.


Patients accrued


Patients with multiple myeloma


Number of approved sites


Biobank participants

Latest news

Rare Disease Day, Tuesday 28 February!!
25 Feb 2023

The MRDR supports Rare Disease Day 2023 😊

Read more
MRDR reaches 5800 patients!
21 Dec 2022

The MRDR has reached 5800 registered patients!

Read more
New MRDR publication
17 Nov 2022

Paper on the second revision of the International Staging System (R2-ISS) accepted for publication!

Read more
MRDR at 4th National Myeloma Workshop
17 Nov 2022

The MRDR was recently represented at the 4th National Myeloma Workshop.

Read more

Participating organisations